4.4 Article

A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis

Kurt-Wolfram Suehs et al.

ANNALS OF NEUROLOGY (2012)

Article Biochemistry & Molecular Biology

Erythropoietin Attenuates Neurological and Histological Consequences of Toxic Demyelination in Mice

Nora Hagemeyer et al.

MOLECULAR MEDICINE (2012)

Article Pharmacology & Pharmacy

Evaluation of the role of erythropoietin and methotrexate in multiple sclerosis

Sandipan Dasgupta et al.

INDIAN JOURNAL OF PHARMACOLOGY (2011)

Article Clinical Neurology

Review: Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis

Claudia Bartels et al.

Therapeutic Advances in Neurological Disorders (2008)

Article Clinical Neurology

Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis

Hannelore Ehrenreich et al.

BRAIN (2007)

Article Biochemistry & Molecular Biology

Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis

MB Sättler et al.

CELL DEATH AND DIFFERENTIATION (2004)

Article Clinical Neurology

Beneficial effect of erythropoietin on experimental allergic encephalomyelitis

WP Li et al.

ANNALS OF NEUROLOGY (2004)